Skip to content
Menu

Ligand Pharmaceuticals: Q4 Earnings Insights

Benzinga Insights 8 months ago

Earnings

Ligand Pharmaceuticals (NASDAQ:LGND) released its Q4 earnings on Thursday, February 26, 2026 at 07:00 AM.

Here's what's important from the earnings announcement.

Earnings

Ligand Pharmaceuticals beat estimated earnings by 75.65%, reporting an EPS of $2.02 versus an estimate of $1.15.

Revenue was up $16.85 million from the same period last year.

Earnings History Overview

In the previous quarter, the company beat on EPS by $1.52, resulting in a 2.76% drop change in the share price the following day.

Here's a look at Ligand Pharmaceuticals's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate 1.57 0.94 1.21 1.19
EPS Actual 3.09 1.60 1.33 1.27
Revenue Estimate 58.54M 44.58M 37.84M 39.03M
Revenue Actual 115.46M 47.63M 45.33M 42.81M

To track all earnings releases for Ligand Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Read at benzinga.com